Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul-Aug;59(4):297-301.
doi: 10.4103/0301-4738.81998.

Profile of retinal vasculitis in a tertiary eye care center in Eastern India

Kumar Saurabh  1 , Radha R Das, Jyotirmay Biswas, Amitabh Kumar
Affiliations

Profile of retinal vasculitis in a tertiary eye care center in Eastern India

Kumar Saurabh et al. Indian J Ophthalmol. 2011 Jul-Aug.

Abstract

Aims: To provide a fact file on the etiology, clinical presentations and management of retinal vasculitis in Eastern India.

Materials and methods: Retrospective, record based analysis of retinal vasculitis cases in a tertiary care center in Eastern India from January 2007 to December 2009 .

Results: One hundred and thirteen eyes of 70 patients of retinal vasculitis were included in this study. Sixty (85.7%) patients were male (mean age 33± 11.1 years) and 10 (14.3%) were female (mean age 32.4 ± 13.6 years). Vasculitis was bilateral in 43 (61.4%) and unilateral in 27 (38.6%) patients. Commonest symptoms were dimness of vision (73; 64.6%) and floaters (36; 31.9%). Vascular sheathing (82; 72.6%) and vitritis (51; 45.1%) were commonest signs. Mantoux test was positive in 21 (30%) patients but tuberculosis was confirmed in only four (5.71%) patients. Raised serum angiotensin-converting enzyme level and positive antinuclear antibody level were reported in four (5.71%) patients each. Human leukocyte antigen B5 (HLA B5) marker was present in one (1.4%) patient. However, none of the total 70 patients were found to have a conclusively proven systemic disease attributable as the cause of retinal vasculitis. Oral corticosteroid (60; 85.7%) was the mainstay of treatment. Forty-eight (42.5%) eyes maintained their initial visual acuity and 43 (38%) gained one or more line at mean follow-up of 16.6± 6.3 months.

Conclusion: Retinal vasculitis cases had similar clinical presentations and common treatment plan. There was no systemic disease association with vasculitis warranting a careful approach in prescribing investigations.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Color fundus photograph showing normal posterior pole with resolving vitreous hemorrhage inferiorly
Figure 2
Figure 2
Fluorescein angiogram of patient in figure 1 showing profuse leakage from new vessels in periphery
Figure 3
Figure 3
Color fundus montage showing vascular sheathing (solid arrow) and previous sectoral laser marks (blank arrow)
Figure 4
Figure 4
Fluorescein angiogram of patient in figure 3 showing peripheral capillary nonperfusion area (solid arrow) and collateral vessels (blank arrow)
See this image and copyright information in PMC

Comment in

References

    1. Sanders MD. Retinal vasculitis: A review. J R Soc Med. 1979;72:908–15. - PMC - PubMed
    1. Walton RC, Ashmore ED. Retinal vasculitis. Curr Opin Ophthalmol. 2003;14:413–9. - PubMed
    1. Abu El-Asrar AM, Herbort CP, Tabbara KF. Retinal vasculitis. Ocul Immunol Inflamm. 2005;13:415–33. - PubMed
    1. Graham EM, Stanford MR, Sanders MD, Kasp E, Dumonde DC. A point prevalence study of 150 cases of idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol. 1989;73:714–21. - PMC - PubMed
    1. Perez VL, Chavala SH, Ahmed M, Chu D, Zafirakis P, Baltatzis S, et al. Ocular manifestations and concepts of systemic vasculitides. Surv Ophthalmol. 2004;49:399–418. - PubMed

MeSH terms

Substances